Candel Therapeutics
Biotechnology-Research
Website
Company Tagline
An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.
Industry Category
Business Keywords
Company Description
Candel Therapeutics is a pioneering biotechnology research company dedicated to empowering the patient's immune system to fight cancer through innovative, off-the-shelf multimodal biological immunotherapies. With a focus on developing cutting-edge treatments, Candel Therapeutics is committed to making a significant impact in the lives of patients battling cancer.
Located at 117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US, Candel Therapeutics has established two clinical-stage multimodal biological immunotherapy platforms. These platforms are based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. The company's lead product candidates, CAN-3110 and CAN-2409, are currently undergoing clinical trials, showcasing Candel Therapeutics' dedication to advancing cancer treatment.
Candel Therapeutics invites you to learn more about its groundbreaking work and commitment to innovation in biotechnology. We encourage the manager of Candel Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and drive commercial development.
Candel Therapeutics est une entreprise de recherche biotechnologique pionnière qui se consacre à donner au système immunitaire du patient les moyens de lutter contre le cancer grâce à des immunothérapies biologiques multimodales innovantes et prêtes à l'emploi. En mettant l'accent sur le développement de traitements de pointe, Candel Therapeutics s'engage à avoir un impact significatif dans la vie des patients qui luttent contre le cancer.
Située au 117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, États-Unis, Candel Therapeutics a mis en place deux plateformes d'immunothérapie biologique multimodale en phase clinique. Ces plateformes sont basées respectivement sur des constructions géniques d'adénovirus et d'herpès simplex virus (HSV)Novel, génétiquement modifiés. Les principaux produits candidats de la société, CAN-3110 et CAN-2409, sont actuellement en cours d'essais cliniques, ce qui témoigne de l'engagement de Candel Therapeutics à faire progresser le traitement du cancer.
Candel Therapeutics vous invite à en savoir plus sur son travail révolutionnaire et son engagement en faveur de l'innovation en biotechnologie. Nous encourageons le responsable de Candel Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence ses réalisations et de stimuler le développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Candel Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Candel TherapeuticsMain Company |
Poseida Therapeutics...View Profile |
CDR-Life Inc.View Profile |
NeoPhore LtdView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2017 | 2017 |
|
Company Size
|
— | 201-500 | 51-200 | 2-10 |
|
City
|
Needham, Massachusetts | San Diego, California | Horgen, Zurich | Cambridge, Cambridgeshire |
|
Country
|
United States | United States | Switzerland | United Kingdom |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Immunotherapy
Oncology
Cancer Research
Viral Immunotherapy
Gene Therapy
Pharmaceuticals
Brain Cancer
Prostate Cancer
Immuno-oncology
|
20 Total
2 Common
18 Unique
Match
20%
Common Skills:
Gene Therapy
Immunotherapy
Unique Skills:
Adoptive Cell Therapy
Allogeneic
CAR-T cells
Cas-CLOVER™
Cell Therapy
Cytotoxic T Lymphocytes
+12
|
7 Total
7 Unique
Unique Skills:
Antibody fragments
Cancer
Drug development
Entrepreneurship
Ophthalmology
Targeted immuno-therapies
+1
|
5 Total
5 Unique
Unique Skills:
Cancer
Drug Discovery
Genetics
Small Molecule Therapeutics
Translational Medicine
|
4
Total Companies2014
Oldest Founded3
Countries39
Unique SkillsSimilar Companies
Other organizations in the same industry
CellectGen, Inc.
Biotechnology-ResearchCreating solutions that make early detection of disease a snap
Quintara Biosciences
Biotechnology-ResearchWe go fast. So you can move forward.
CUROGEN
Biotechnology-ResearchThe Next Generation of Autoimmune Disease
Alternative Company Names
This company is also known as